Your browser doesn't support javascript.
loading
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.
Das, Rajdeep; Gregory, Philip A; Fernandes, Rayzel C; Denis, Iza; Wang, Qingqing; Townley, Scott L; Zhao, Shuang G; Hanson, Adrienne R; Pickering, Marie A; Armstrong, Heather K; Lokman, Noor A; Ebrahimie, Esmaeil; Davicioni, Elai; Jenkins, Robert B; Karnes, R Jeffrey; Ross, Ashley E; Den, Robert B; Klein, Eric A; Chi, Kim N; Ramshaw, Hayley S; Williams, Elizabeth D; Zoubeidi, Amina; Goodall, Gregory J; Feng, Felix Y; Butler, Lisa M; Tilley, Wayne D; Selth, Luke A.
Affiliation
  • Das R; Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Gregory PA; Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Fernandes RC; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, South Australia, Australia.
  • Denis I; School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
  • Wang Q; Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Townley SL; Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Zhao SG; Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Hanson AR; Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Pickering MA; Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Armstrong HK; Breast Cancer Genetics Group, Centre for Personalised Cancer Medicine, School of Medicine, The University of Adelaide, SA 5005, Australia.
  • Lokman NA; Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Ebrahimie E; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
  • Davicioni E; Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Jenkins RB; Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Karnes RJ; Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Ross AE; Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Den RB; Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, Robinson Institute, University of Adelaide, Adelaide, South Australia, Australia.
  • Klein EA; Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia.
  • Chi KN; GenomeDx Biosciences Inc., Vancouver, British Columbia, Canada.
  • Ramshaw HS; Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.
  • Williams ED; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Zoubeidi A; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland.
  • Goodall GJ; Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
  • Feng FY; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
  • Butler LM; The Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Tilley WD; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Selth LA; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, South Australia, Australia.
Cancer Res ; 77(4): 1021-1034, 2017 02 15.
Article in En | MEDLINE | ID: mdl-28011622

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / MicroRNAs / Suppressor of Cytokine Signaling Proteins Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cancer Res Year: 2017 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / MicroRNAs / Suppressor of Cytokine Signaling Proteins Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cancer Res Year: 2017 Type: Article Affiliation country: Australia